Garry Blakely of the University of Edinburgh in the United Kingdom will engineer a common gut bacterium to express antigens from pathogens that cause diarrhea onto nanoscale outer membrane vesicles. These nanoparticles could be the basis for a new generation of biocompatible oral vaccines that will protect against diarrheal disease.
Grant ID
OPP1043904
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False